A research team has developed an innovative injectable adhesive hydrogel for bone regeneration. This hydrogel utilizes harmless visible light to simultaneously achieve cross-linking and mineralization without the need for bone grafts. The research was recently published in the journal Biomaterials.
When children receive their second measles-mumps-rubella vaccine, around the time they start kindergarten, they gain protection against all three viruses for all or most of their lives. Yet the effectiveness of an influenza vaccine given in October starts to wane by the following spring.
Researchers at the University of Pittsburgh have developed a nasal swab test for kids that diagnoses specific asthma subtype, or endotype. This non-invasive approach could help clinicians prescribe medications more precisely and pave the way for research toward better treatments for lesser-studied asthma types, which have been difficult to diagnose accurately until now.
Researchers from the Bakkers group at the Hubrecht Institute have successfully repaired damaged mouse hearts using a protein from zebrafish. They discovered that the protein Hmga1 plays a key role in heart regeneration in zebrafish. In mice, this protein was able to restore the heart by activating dormant repair genes without causing side effects, such as heart enlargement.
Whether people decide to make New Year’s resolutions or not, they might want to lead a healthier lifestyle in 2025. According to a new University of Bristol-led study, smartwatches could help people give up smoking.
SINGAPORE, Jan. 2, 2025 /PRNewswire/ — Genesis Medtech is proud to announce that iReach Omnia, the world’s first powered stapler with 90° articulation capability, has been approved for market release in China by the National Medical Products Administration (NMPA). Independently developed by Genesis Medtech, this innovation addresses key challenges in complex laparoscopic surgeries by enabling surgeons with unprecedented precision and access in tight and deep anatomical positions.
Monitoring molecular changes in the brain caused by cancer and other neurological pathologies in a non-invasive way is one of the major challenges in biomedical research. A new experimental technique has achieved this by introducing light into the brains of mice using an ultra-thin probe.
Autonomix today announced it received a patent from the U.S. Patent and Trademark Office (USPTO) for its catheter-based cancer tumor treating technology.
A Korea Institute of Science and Technology (KIST) research team has developed a novel stent surface treatment technology using laser patterning. This technology promotes endothelial cell growth while inhibiting smooth muscle cell dedifferentiation in blood vessels.
Mayo Clinic researchers have identified interleukin-23 receptor (IL-23R) as a significant biomarker of cellular senescence and aging in both mice and humans. Experiments show that IL-23R levels in the bloodstream increase with age and can decrease, reflecting senescent cell clearing, with senolytic therapies.